These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16264358)

  • 1. FDG PET imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation.
    O'Conner AR; Franc BL
    Nucl Med Commun; 2005 Dec; 26(12):1107-11. PubMed ID: 16264358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.
    Vali R; Punnett A; Bajno L; Moineddin R; Shammas A
    Pediatr Transplant; 2015 Dec; 19(8):932-9. PubMed ID: 26515450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder.
    Takehana CS; Twist CJ; Mosci C; Quon A; Mittra E; Iagaru A
    Nucl Med Commun; 2014 Mar; 35(3):276-81. PubMed ID: 24296883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease.
    Bianchi E; Pascual M; Nicod M; Delaloye AB; Duchosal MA
    Transplantation; 2008 Mar; 85(5):707-12. PubMed ID: 18337664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring.
    von Falck C; Maecker B; Schirg E; Boerner AR; Knapp WH; Klein C; Galanski M
    Eur J Radiol; 2007 Sep; 63(3):427-35. PubMed ID: 17293073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG-PET/CT in abdominal post-transplant lymphoproliferative disease.
    Metser U; Lo G
    Br J Radiol; 2016; 89(1057):20150844. PubMed ID: 26544161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of 18F-FDG PET/CT in the evaluation of pediatric transplant patients.
    Yang J; Zhuang H
    Hell J Nucl Med; 2015; 18(2):136-9. PubMed ID: 26187213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis of post-transplant lymphoproliferative disorder.
    Panagiotidis E; Quigley AM; Pencharz D; Ardeshna K; Syed R; Sajjan R; Bomanji J
    Leuk Lymphoma; 2014 Mar; 55(3):515-9. PubMed ID: 23772644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin lymphoma post-transplant lymphoproliferative disorder following pediatric renal transplant: serial imaging with F-18 FDG PET/CT.
    Makis W; Lisbona R; Derbekyan V
    Clin Nucl Med; 2010 Sep; 35(9):704-5. PubMed ID: 20706047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysis.
    Montes de Jesus FM; Kwee TC; Nijland M; Kahle XU; Huls G; Dierckx RAJO; van Meerten T; Gheysens O; Dierickx D; Vergote V; Noordzij W; Glaudemans AWJM
    Crit Rev Oncol Hematol; 2018 Dec; 132():27-38. PubMed ID: 30447925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary experience on the use of PET/CT in the management of pediatric post-transplant lymphoproliferative disorder.
    Guerra-García P; Hirsch S; Levine DS; Taj MM
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28612477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography scanning in the setting of post-transplant lymphoproliferative disorders.
    Blaes AH; Cioc AM; Froelich JW; Peterson BA; Dunitz JM
    Clin Transplant; 2009; 23(6):794-9. PubMed ID: 20447185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography with fluoro-2-deoxy-D-glucose (FDG-PET) in the staging of post transplant lymphoproliferative disorder in lung transplant recipients.
    Marom EM; McAdams HP; Butnor KJ; Coleman RE
    J Thorac Imaging; 2004 Apr; 19(2):74-8. PubMed ID: 15071322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy.
    Gheysens O; Thielemans S; Morscio J; Boeckx N; Goffin KE; Deroose CM; Sagaert X; Wlodarska I; Verhoef G; Dierickx D; Tousseyn T
    Leuk Lymphoma; 2016 Oct; 57(10):2382-8. PubMed ID: 26854937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both native and ectopically transplanted hearts shown on FDG PET/CT in a PTLD patient.
    Sonoda LI; Sanghera B; Gogbashian A; Lambert J; Wong WL
    Clin Nucl Med; 2012 Oct; 37(10):1022-3. PubMed ID: 22899204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD Registry.
    Zimmermann H; Denecke T; Dreyling MH; Franzius C; Reinke P; Subklewe M; Amthauer H; Kneba M; Riess H; Trappe RU
    Transplantation; 2018 May; 102(5):868-875. PubMed ID: 29189632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET/CT staging and response evaluation of post-transplantation lymphoproliferative disease (PTLD).
    Chowdhury FU; Sheerin F; Bradley KM; Gleeson FV
    Clin Nucl Med; 2009 Jun; 34(6):386-7. PubMed ID: 19487854
    [No Abstract]   [Full Text] [Related]  

  • 18. Epstein-Barr DNA serology and positron-emission tomography imaging of the head and neck in pediatric transplant recipients.
    Sidell D; Venick RS; Shapiro NL
    Laryngoscope; 2014 May; 124(5):1236-41. PubMed ID: 24105893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of F-18 FDG PET/CT in the evaluation of neck swelling in polymorphic posttransplant lymphoproliferative disorder after renal transplantation.
    Kim SH; Zeon SK; Choi BW; Kim HW; Won KS; Kim SJ
    Clin Nucl Med; 2011 Jul; 36(7):587-9. PubMed ID: 21637068
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Montes de Jesus FM; Glaudemans AWJM; Tissing WJ; Dierckx RAJO; Rosati S; Diepstra A; Noordzij W; Kwee TC
    J Nucl Med; 2020 Sep; 61(9):1307-1313. PubMed ID: 32005775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.